See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2016_Propanc_Biopharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'ComprehensiveNetIncome', 'value': -9380056, 'size_variable': 'Assets', 'size_value': 379142, 'ratio': 24.7, 'threshold': 20} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 621,890 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,494 |
| 3 | remainder_Assets | 1,684 |
| 4 | LiabilitiesCurrent | 3,680,584 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,567,549 |
| 9 | ResearchAndDevelopmentExpense | 134,319 |
| 10 | remainder_Expenses | -73,751 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,784,637 |
| 13 | remainder_ComprehensiveNetIncome | 403,831 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 627,068 |
| 1 | Liabilities | 3,680,584 |
| 2 | Expenses | 1,628,117 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,053,516 |
| 5 | NetIncome | -3,412,754 |
| 6 | ComprehensiveNetIncome | -3,210,838 |
| 7 | BaseVar | 4,062,118 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.58 |
| 9 | EconomicCapitalRatio | 0.263 |
Edgar->Model Mapping
Feature Distribution
Change over Time
